SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Brooks M. Breast cancer screening and biomarkers. Methods Mol Biol. 2009; 472: 307-321.
  • 2
    Nothacker M, Duda V, Hahn M, et al. Early detection of breast cancer: benefits and risks of supplemental breast ultrasound in asymptomatic women with mammographically dense breast tissue. A systematic review. BMC Cancer. 2009; 9: 335.
  • 3
    Swain SM. Chemotherapy: updates and new perspectives. Oncologist. 2011; 16( suppl 1): 30-39.
  • 4
    Kirova YM. Recent advances in breast cancer radiotherapy: Evolution or revolution, or how to decrease cardiac toxicity? World J Radiol. 2010; 2: 103-108.
  • 5
    Iwuchukwu OC, Wahed S, Wozniak A, Dordea M, Rich A. Recent advances in non-invasive axillary staging for breast cancer. Surg Oncol. 2011; 20: 253-258.
  • 6
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90.
  • 7
    Smoot B, Wong J, Cooper B, et al. Upper extremity impairments in women with or without lymphedema following breast cancer treatment. J Cancer Surviv. 2010; 4: 167-178.
  • 8
    Rietman JS, Dijkstra PU, Debreczeni R, Geertzen JH, Robinson DP, De Vries J. Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery. Disabil Rehabil. 2004; 26: 78-84.
  • 9
    Hayes SC, Rye S, Battistutta D, DiSipio T, Newman B. Upper-body morbidity following breast cancer treatment is common, may persist longer-term and adversely influences quality of life. Health Qual Life Outcomes. 2010; 8: 92.
  • 10
    Rietman JS, Dijkstra PU, Hoekstra HJ, et al. Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol. 2003; 29: 229-238.
  • 11
    Institute of Medicine. Clinical practice guidelines we can trust. Washington, DC: The National Academies Press; 2011.
  • 12
    Foureur M, Ryan CL, Nicholl M, Homer C. Inconsistent evidence: analysis of six national guidelines for vaginal birth after cesarean section. Birth. 2010; 37: 3-10.
  • 13
    Ou Y, Goldberg I, Migdal C, Lee PP. A critical appraisal and comparison of the quality and recommendations of glaucoma clinical practice guidelines. Ophthalmology. 2011; 18: 1017-1023.
  • 14
    Burda BU, Norris SL, Holmer HK, Ogden LA, Smith ME. Quality varies across clinical practice guidelines for mammography screening in women aged 40-49 years as assessed by AGREE and AMSTAR instruments. J Clin Epidemiol. 2011; 64: 968-976.
  • 15
    AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care. 2003; 12: 18-23.
  • 16
    Brouwers MC, Kho ME. Browman GP, Burgers JS, Cluzeau F, Feder G, et al; AGREE Next Steps Consortium. Development of the AGREE II, part 1: performance, usefulness and areas for improvement. CMAJ. 2010; 182: 1045-1052.
  • 17
    Brouwers MC, Kho ME. Browman GP, Burgers JS, Cluzeau F, Feder G, et al; AGREE Next Steps Consortium. Development of the AGREE II, part 2: assessment of validity of items and tools to support application. CMAJ. 2010; 182: E472-E478.
  • 18
    AGREE Next Steps Consortium. The AGREE II Instrument [electronic version]. http://www.agreetrust.org. Accessed May 22, 2011.
  • 19
    National Institute for Health and Clinical Excellence (NICE). Breast cancer (early & locally advanced): diagnosis and treatment. http://guidance.nice.org.uk/CG80. Accessed May 4, 2011.
  • 20
    National Institute for Health and Clinical Excellence (NICE). Advanced breast cancer: diagnosis and treatment. http://guidance.nice.org.uk/CG81. Accessed May 5, 2011.
  • 21
    Vlayen J, Aertgeerts B, Hannes K, Sermeus W, Ramaekers D. A systematic review of appraisal tools for clinical practice guidelines: multiple similarities and one common deficit. Int J Qual Health Care. 2005; 17: 235-242.
  • 22
    Burls A. AGREE II–improving the quality of clinical care. Lancet. 2010; 376: 1128-1129.
  • 23
    Stout NL, Binkley JM, Schmitz KH, et al. A prospective surveillance model for women with breast cancer. Cancer. 2012; 118( suppl 8): 2191-2200.
  • 24
    Agency for Healthcare Research and Quality (AHRQ). Clinical practice guidelines. http://www.ahrq.gov/clinic/cpgsix.htm. Accessed May 4, 2011.
  • 25
    American Society of Clinical Oncology (ASCO). Practice and guidelines: breast cancer. http://www.asco.org/ascov2/Practice++Guidelines/Guidelines/Clinical+Practice+Guidelines/Breast+Cancer. Accessed May 1, 2011.
  • 26
    British Columbia Cancer Agency (BCCA). Practice Guidelines Websites. http://www.bccancer.bc.ca/PPI/RecommendedLinks/info tools/practice_guidelines.htm. Accessed May 3, 2011.
  • 27
    Canadian Breast Cancer Network (CBCN). Breast cancer, pregnancy, and breastfeeding: SOGC clinical practice guidelines. Society of Obstetricians and Gynecologists of Canada: Clinical practice guidelines no. III. February 2002. http://64.26.166.131/en/index. php?section=3&category=760&regionid=&page=11498. Accessed May 6, 2011.
  • 28
  • 29
    Kligman L, Wong R, Johnston M, Laetsch N; Supportive Care Guidelines Group. Cancer Care Ontario. The treatment of lymphedema related to breast cancer. Evidence summary report #13-1. Program in evidence-based care. Published August 22, 2003. http://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=14306. Accessed May 7, 2011.
  • 30
    Canadian Medical Association (CMA) Infobase. Clinical practice guidelines: breast cancer. http://mdm.ca/cpgsnew/cpgs/search/english/help/ht_breastcpg.htm. Accessed May 7, 2011.
  • 31
    Canadian Medical Association Journal (CMAJ). Clinical practice guidelines for the care and treatment of breast cancer. http://www.cmaj.ca/cgi/content/full/158/3/DC1. Accessed May 7, 2011.
  • 32
    European Society for Medical Oncology (ESMO). ESMO clinical practice guidelines. May 2010: vol. 21, supplement no. 5. http://www.esmo.org/research/esmo-clinical-practice-guidelines.html#c3338. Accessed May 5, 2011.
  • 33
    National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed May 7, 2011.
  • 34
    Agency for Healthcare Research and Quality. National Guideline Clearing House. Breast cancer. http://www.guideline.gov/search/search.aspx?term=breast+cancer. Accessed May 7, 2011.
  • 35
    Australian National Health and Medical Research Council (NHMRC). Clinical practice guidelines for the management of early breast cancer. Edition 2. Reference no. CP74. http://www.nhmrc. gov.au/guidelines/publications/cp74. Accessed May 3, 2011.
  • 36
    UK National Health Service (NHS). NHS Evidence–cancer. Breast cancer: treatment and disease management: UK and international guidelines. http://www.library.nhs.uk/Cancer/ViewResource.aspx?res ID=155141&tabID=288&catID=8144. Accessed May 6, 2011.
  • 37
    Public Health Agency of Canada. Disease prevention and control guidelines: Cancer. http://www.phac-aspc.gc.ca/dpg-eng.php#cancer. Accessed May 7, 2011.
  • 38
    Scottish Intercollegiate Guidelines Network (SIGN). Guidelines by topic: cancer. http://www.sign.ac.uk/guidelines/published/index. html#Cancer. Accessed May 6, 2011.
  • 39
    New Zealand Guidelines Group. Management of early breast cancer. http://www.nzgg.org.nz/index.cfm. Accessed May 27, 2011.
  • 40
    Cancer View Canada. Cancer Guidelines Resource Centre. SAGE (Standards and Guidelines Excellence). http://www.cancerview.ca/portal/server.pt/community/sage/521. Accessed May 30, 2011.
  • 41
    Visvanathan K, Chlebowski RT, Hurley P, et al. American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. J Clin Oncol. 2009; 27: 3235-3258.
  • 42
    Cardoso F, Senkus-Konefka E, Fallowfield L, Costa A, Castiglione M; ESMO Guidelines Working Group. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010; 21( suppl 5): v15-v19.
  • 43
    Harris SR, Hugi M, Olivotto IA, et al. Upper extremity rehabilitation after axillary dissection for the treatment of breast cancer: clinical practice guidelines. Crit Rev Phys Med Rehab. 2001; 13: 91-103.
  • 44
    BC Cancer Agency. Cancer management guidelines–breast. 8. Upper extremity rehab after axillary dissection. http://www.bccancer.bc.ca/HPI/CancerManagementGuidelines/Breast/Physiotherapy/default.htm. Accessed on May 29, 2011.
  • 45
    Harris SR, Hugi MR, Olivotto IA, Levine M; Steering Committee for Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema. CMAJ. 2001; 164: 191-199.
  • 46
    National Breast and Ovarian Cancer Centre. Review of research evidence on secondary lymphoedema: Incidence, prevention, risk factors and treatment. NBOCC: Surry Hills, Australia; 2008.
  • 47
    Kligman L, Wong RKS, Johnston M, Laetsch NS; Members of the Supportive Care Guidelines Group of Cancer Care Ontario's Program in Evidence-Based Care. The treatment of lymphedema related to breast cancer: a systematic review and evidence summary. Supp Care Cancer. 2004; 12: 421-431.
  • 48
    Poage E, Singer M, Armer J, Poundall M, Shellabarger MJ. Demystifying lymphedema: development of the lymphedema putting evidence into practice card. Clin J Oncol Nurs. 2008; 12: 951-964.
  • 49
    Emery C, Gallagher R, Hugi M, Levine M; Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: 10. The management of chronic pain in patients with breast cancer (2001 update). Published October 9, 2001. http://www.cmaj.ca/content/suppl/2003/06/03/165.9.1218.DC1/update10-technical-final.pdf. Accessed May 10, 2011.
  • 50
    Emery C, Gallagher R, Hugi M, Levine M; Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer (summary of the 2001 update). CMAJ. 2001; 167: 14-15.
  • 51
    Swarm R, Abernethy AP, Anghelescu DL, et al; NCCN Adult Cancer Pain. Adult cancer pain. J Natl Compr Canc Netw. 2010; 8: 1046-1086.
  • 52
    National Health Service Quality Improvement Scotland. Scottish Intercollegiate Guidelines Network (SIGN). Guideline 106. Control of pain in adults with cancer: a national clinical guideline. Published November 2008. http://www.sign.ac.uk/guidelines/fulltext/106/index.html. Accessed May 6, 2011.
  • 53
    Jost L, Roila F; ESMO Guidelines Working Group. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol. 2010; 21( suppl 5): v267-v260.
  • 54
    Cancer-related Pain Management Working Panel. Cancer-related pain management: a report of evidence-based recommendations to guide practice. Evidence-Based Series #16-2: Section 1: Recommendations. Published March 17, 2008. Program in Evidence-Based Care. Cancer Care Ontario. www.cancercare.on.ca/pdf/pebc16-2s.pdf. Accessed January 30, 2012.
  • 55
    Gordon DB, Dahl JL, Miaskowski C, et al. American pain society recommendations for improving the quality of acute and cancer pain management: American Pain Society Quality of Care Task Force. Ann Intern Med. 2005; 165: 1574-1580.
  • 56
    Berger AM, Abernethy AP, Atkinson A, et al. Cancer-related fatigue. J Natl Compr Canc Netw. 2010; 8: 904-931.
  • 57
    Mitchell SA, Beck SL. ONS PEP resource: fatigue. In: Eaton LH, Tipton JM, editors. Putting Evidence into Practice: Improving Oncology Patient Outcomes. Pittsburgh, PA: Oncology Nursing Society, 2009: 149-174. http://www.ons.org/Research/PEP/Fatigue. Accessed August 18, 2011.
  • 58
    Visovsky C, Collins M, Abbott L, Aschenbrenner J, Hart C. Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs. 2007; 11: 901-913.
  • 59
    Stubblefield MD, Burstein HJ, Burton AW, et al. NCCN task force report: management of neuropathy in cancer. J Natl Compr Canc Netw. 2009; 7( suppl 5): S1-S26.
  • 60
    Martin M, Esteva FJ, Alba E, et al. Minimizing cardiotoxicity while optimizing treatment efficacy with trastuzumab: review and expert recommendations. Oncologist. 2009; 14: 1-11.
  • 61
    Bovelli D, Plataniotis G, Roila F; ESMO Guidelines Working Group. Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines. Ann Oncol. 2010; 21( suppl 5): v277-v282.
  • 62
    Gralow JR, Biermann JS, Farooki A, et al. NCCN Task Force Report: bone health in cancer care. J Natl Compr Canc Netw. 2009; 7( suppl 3): S1-S32.
  • 63
    Hillner BE, Ingle JN, Chlebowski RT,et al; American Society of Clinical Oncology, American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol. 2003; 21: 4042-4057.
  • 64
    Grunfeld E, Dhesy-Thind S, Levine M; Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ. 2005; 172: 1319-1320.
  • 65
    Aebi S, Davidson T, Gruber G, Castiglione M; ESMO Guidelines Working Group. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010; 21( suppl 5): v9-v14.
  • 66
    Doyle C, Kushi LH, Byers T, et al; 2006 Nutrition Physical Activity and Cancer Survivorship Advisory Committee, American Cancer Society. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin. 2006; 56: 323-353.
  • 67
    Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008; 112: 2809-2819.
  • 68
    Cheema B, Gaul CA, Lane K, Fiatarone Singh MA. Progressive resistance training in breast cancer: a systematic review of clinical trials. Breast Cancer Res Treat. 2007; 109: 9-26.
  • 69
    Schmitz KH, Ahmed RL, Troxel AB, et al. Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med. 2009; 361: 664-673.
  • 70
    Torres Lacomba M, Yuste Sánchez MJ, Zapico Goñi A, et al. Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial. BMJ. 2010; 340: b5396. doi:10.1136/bmj.b5396.
  • 71
    McNeely ML, Peddle CJ, Yurick JL, Dayes IS, Mackey JR. Conservative and dietary interventions for cancer-related lymphedema: a systematic review and meta-analysis. Cancer. 2011; 117: 1136-1148.
  • 72
    McNeely ML, Campbell K, Ospina M, et al. Exercise interventions for upper-limb dysfunction due to breast cancer treatment. Cochrane Database Syst Rev. 2010;( 6): CD005211.